Tawfiq, Reema K.
Abeykoon, Jithma P.
Kapoor, Prashant
Article History
Accepted: 26 February 2024
First Online: 27 March 2024
Declarations
:
: RKT and JPA declare no competing interests. P.K is the principal investigator of trials for which Mayo Clinic has received research funding from Amgen, Regeneron, Bristol Myers Squibb, Loxo Pharmaceuticals, Ichnos, Karyopharm, Sanofi, AbbVie and GlaxoSmithKline. Prashant Kapoor has served on the Advisory Boards of BeiGene, Mustang Bio, Pharmacyclics, X4 Pharmaceuticals, AstraZeneca, Kite, Oncopeptides, Angitia Bio, GlaxoSmithKline, AbbVie and Sanofi.
: This article does not contain any studies with human or animal subjects performed by any of the authors.